X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (628) 628
Book Review (115) 115
Publication (104) 104
Book Chapter (39) 39
Conference Proceeding (8) 8
Dissertation (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (551) 551
animals (457) 457
humans (283) 283
mice (232) 232
morpholinos - administration & dosage (135) 135
expression (123) 123
antisense oligonucleotides (114) 114
morpholino (114) 114
medicine, research & experimental (107) 107
male (100) 100
pharmacology & pharmacy (97) 97
proteins (97) 97
biochemistry & molecular biology (95) 95
zebrafish (95) 95
morpholinos (92) 92
disease models, animal (91) 91
morpholinos - genetics (87) 87
mutation (85) 85
female (77) 77
muscular dystrophy, duchenne - genetics (77) 77
oligonucleotides, antisense - administration & dosage (76) 76
article (75) 75
gene expression (75) 75
duchenne muscular-dystrophy (74) 74
dystrophin - genetics (71) 71
oligonucleotides (71) 71
gene (70) 70
in-vivo (70) 70
exon skipping (69) 69
genetics (69) 69
oligomers (68) 68
oligonucleotides, antisense - genetics (67) 67
antisense (66) 66
duchenne muscular dystrophy (65) 65
multidisciplinary sciences (65) 65
genetics & heredity (64) 64
rodents (64) 64
analysis (63) 63
biotechnology & applied microbiology (63) 63
morpholinos - pharmacology (63) 63
exons (61) 61
muscular dystrophy (61) 61
research article (61) 61
developmental biology (60) 60
gene knockdown techniques (60) 60
research (60) 60
zebrafish - genetics (60) 60
health aspects (59) 59
morpholino oligomers (59) 59
dystrophin (58) 58
molecular biology (57) 57
muscular dystrophy, duchenne - therapy (56) 56
zebrafish proteins - genetics (53) 53
cell biology (51) 51
medicine (51) 51
base sequence (50) 50
zebrafish - embryology (50) 50
genes (49) 49
mice, inbred mdx (48) 48
rna (48) 48
animal models (46) 46
biochemistry (45) 45
peptides (45) 45
gene-expression (44) 44
morpholinos - therapeutic use (44) 44
neurosciences (44) 44
protein (44) 44
genetic therapy - methods (43) 43
zebrafish proteins - metabolism (43) 43
genetic aspects (42) 42
oligonucleotides, antisense - pharmacology (42) 42
cells (40) 40
mouse (40) 40
congenital, hereditary, and neonatal diseases and abnormalities (39) 39
molecular sequence data (39) 39
pharmacology (39) 39
restoration (39) 39
rna interference (39) 39
science (39) 39
systemic delivery (39) 39
delivery (38) 38
mice, inbred c57bl (38) 38
morpholines - administration & dosage (38) 38
musculoskeletal diseases (38) 38
inhibition (37) 37
muscle, skeletal - metabolism (37) 37
original (37) 37
phenotype (37) 37
cell line (36) 36
cells, cultured (36) 36
morpholinos - chemistry (36) 36
oligonucleotides, antisense - therapeutic use (36) 36
drug delivery systems (35) 35
messenger-rna (35) 35
embryos (34) 34
muscular dystrophy, duchenne - drug therapy (34) 34
rna splicing (34) 34
amino acid sequence (33) 33
oligonucleotides, antisense - chemistry (33) 33
dose-response relationship, drug (32) 32
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
by Anon
Nature Medicine, ISSN 1078-8956, 11/2016, Volume 22, Issue 11, pp. 1193 - 1193
Journal Article
Journal Article
Journal Article
nucleic acid therapeutics, ISSN 2159-3337, 08/2011, Volume 21, Issue 4, pp. 293 - 298
Duchenne muscular dystrophy (DMD) is a lethal X-linked inherited disease caused by mutations in the dystrophin gene and consequent lack of dystrophin in the... 
Brief Communication | MEDICINE, RESEARCH & EXPERIMENTAL | CHEMISTRY, MEDICINAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | MOUSE | RESTORATION | DEFICIENT MICE | LINKED DILATED CARDIOMYOPATHY | MDX MICE | DELIVERY | RESCUE | GENE | DUCHENNE MUSCULAR-DYSTROPHY | DYSFUNCTION | Exons - drug effects | Gene Expression - drug effects | Muscle, Smooth, Vascular - metabolism | Muscular Dystrophy, Duchenne - drug therapy | Morpholinos - administration & dosage | Morpholinos - therapeutic use | Cardiomyopathies - prevention & control | Male | Muscle, Skeletal - metabolism | Myocardium - pathology | Dose-Response Relationship, Drug | Muscle, Smooth, Vascular - pathology | Animals | Dystrophin - genetics | Cardiomyopathies - metabolism | Myocardium - metabolism | Mice, Inbred mdx | Mice | Myocytes, Smooth Muscle - drug effects | Dystrophin - metabolism | Myocytes, Smooth Muscle - metabolism | Heart Ventricles - pathology | Heart Ventricles - drug effects | Muscle, Smooth, Vascular - drug effects | Cardiology | Skeletal system | Muscular system | Heart | Vigilance | Cardiac muscle | Splicing | X chromosome | Antisense | Data processing | Nervous system | Muscular dystrophy | Skeletal muscle | Hereditary diseases | Duchenne's muscular dystrophy | Exon skipping | Mutation | Dystrophin | Heart diseases | Locomotor activity | Index Medicus
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9791, pp. 595 - 605
Journal Article
Cancer Gene Therapy, ISSN 0929-1903, 02/2008, Volume 15, Issue 2, pp. 126 - 132
The three-component nanoparticle of this investigation consisted of an anti-type I regulatory subunit a of the cyclic AMP-dependent protein kinase A (RI alpha)... 
Herceptin | Nanoparticle | Tat | Antisense MORF | MEDICINE, RESEARCH & EXPERIMENTAL | PROTEIN | antisense MORF | tat | nanoparticle | ANTIBODY | BREAST-CANCER | THERAPY | ONCOLOGY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | DNA | GENETICS & HEREDITY | TAT-STREPTAVIDIN | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Receptor, ErbB-2 - genetics | Humans | Peptides - genetics | Antibodies, Monoclonal - therapeutic use | Receptor, ErbB-2 - administration & dosage | Peptides - administration & dosage | Drug Delivery Systems | Antibodies, Monoclonal, Humanized | Nanoparticles - therapeutic use | Drug Design | Receptor, ErbB-2 - immunology | Morpholines - therapeutic use | tat Gene Products, Human Immunodeficiency Virus - administration & dosage | tat Gene Products, Human Immunodeficiency Virus - genetics | Cyclic AMP-Dependent Protein Kinase RIalpha Subunit - administration & dosage | Morpholines - administration & dosage | Oligonucleotides, Antisense - chemical synthesis | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cyclic AMP-Dependent Protein Kinase RIalpha Subunit - genetics | Cell Line, Tumor | Oligonucleotides, Antisense - administration & dosage | Morpholinos | Nanoparticles - administration & dosage | Trastuzumab | Nanoparticles | Usage | Gene targeting | Physiological aspects | Antisense DNA | Health aspects | Methods | Index Medicus
Journal Article